These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9254055)

  • 1. Obesity in db and ob animals leads to impaired hepatic very low density lipoprotein secretion and differential secretion of apolipoprotein B-48 and B-100.
    Li X; Grundy SM; Patel SB
    J Lipid Res; 1997 Jul; 38(7):1277-88. PubMed ID: 9254055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 studied with a stable isotope technique in men with visceral obesity.
    Riches FM; Watts GF; Naoumova RP; Kelly JM; Croft KD; Thompson GR
    Int J Obes Relat Metab Disord; 1998 May; 22(5):414-23. PubMed ID: 9622338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein B mRNA editing and apolipoprotein gene expression in the liver of hyperinsulinemic fatty Zucker rats: relationship to very low density lipoprotein composition.
    Elam MB; von Wronski MA; Cagen L; Thorngate F; Kumar P; Heimberg M; Wilcox HG
    Lipids; 1999 Aug; 34(8):809-16. PubMed ID: 10529091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Method to measure apolipoprotein B-48 and B-100 secretion rates in an individual mouse: evidence for a very rapid turnover of VLDL and preferential removal of B-48- relative to B-100-containing lipoproteins.
    Li X; Catalina F; Grundy SM; Patel S
    J Lipid Res; 1996 Jan; 37(1):210-20. PubMed ID: 8820116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein B signal peptide and apolipoprotein E genotypes as determinants of the hepatic secretion of VLDL apoB in obese men.
    Riches FM; Watts GF; van Bockxmeer FM; Hua J; Song S; Humphries SE; Talmud PJ
    J Lipid Res; 1998 Sep; 39(9):1752-8. PubMed ID: 9741687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ApoB100 is required for increased VLDL-triglyceride secretion by microsomal triglyceride transfer protein in ob/ob mice.
    Chen Z; Newberry EP; Norris JY; Xie Y; Luo J; Kennedy SM; Davidson NO
    J Lipid Res; 2008 Sep; 49(9):2013-22. PubMed ID: 18519977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory effects of arachidonate 5-lipoxygenase on hepatic microsomal TG transfer protein activity and VLDL-triglyceride and apoB secretion in obese mice.
    López-Parra M; Titos E; Horrillo R; Ferré N; González-Périz A; Martínez-Clemente M; Planagumà A; Masferrer J; Arroyo V; Clària J
    J Lipid Res; 2008 Dec; 49(12):2513-23. PubMed ID: 18645210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotypic associations of the hepatic secretion of VLDL apolipoprotein B-100 in obesity.
    Watts GF; Riches FM; Humphries SE; Talmud PJ; van Bockxmeer FM
    J Lipid Res; 2000 Mar; 41(3):481-8. PubMed ID: 10706596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of ER stress and mTORC1 suppresses hepatic sortilin-1 levels in obese mice.
    Ai D; Baez JM; Jiang H; Conlon DM; Hernandez-Ono A; Frank-Kamenetsky M; Milstein S; Fitzgerald K; Murphy AJ; Woo CW; Strong A; Ginsberg HN; Tabas I; Rader DJ; Tall AR
    J Clin Invest; 2012 May; 122(5):1677-87. PubMed ID: 22466652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic overexpression of microsomal triglyceride transfer protein (MTP) results in increased in vivo secretion of VLDL triglycerides and apolipoprotein B.
    Tietge UJ; Bakillah A; Maugeais C; Tsukamoto K; Hussain M; Rader DJ
    J Lipid Res; 1999 Nov; 40(11):2134-9. PubMed ID: 10553017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein B-100 kinetics in visceral obesity: associations with plasma apolipoprotein C-III concentration.
    Chan DC; Watts GF; Redgrave TG; Mori TA; Barrett PH
    Metabolism; 2002 Aug; 51(8):1041-6. PubMed ID: 12145779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity causes very low density lipoprotein clearance defects in low-density lipoprotein receptor-deficient mice.
    Coenen KR; Gruen ML; Hasty AH
    J Nutr Biochem; 2007 Nov; 18(11):727-35. PubMed ID: 17418556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VLDL output by hepatocytes from obese Zucker rats is resistant to the inhibitory effect of insulin.
    Bourgeois CS; Wiggins D; Hems R; Gibbons GF
    Am J Physiol; 1995 Aug; 269(2 Pt 1):E208-15. PubMed ID: 7653537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic VLDL production in ob/ob mice is not stimulated by massive de novo lipogenesis but is less sensitive to the suppressive effects of insulin.
    Wiegman CH; Bandsma RH; Ouwens M; van der Sluijs FH; Havinga R; Boer T; Reijngoud DJ; Romijn JA; Kuipers F
    Diabetes; 2003 May; 52(5):1081-9. PubMed ID: 12716736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of weight loss on VLDL-triglyceride and apoB-100 kinetics in women with abdominal obesity.
    Mittendorfer B; Patterson BW; Klein S
    Am J Physiol Endocrinol Metab; 2003 Mar; 284(3):E549-56. PubMed ID: 12475754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein B sequence requirements for hepatic very low density lipoprotein assembly. Evidence that hydrophobic sequences within apolipoprotein B48 mediate lipid recruitment.
    McLeod RS; Wang Y; Wang S; Rusiñol A; Links P; Yao Z
    J Biol Chem; 1996 Aug; 271(31):18445-55. PubMed ID: 8702489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PPARalpha deficiency increases secretion and serum levels of apolipoprotein B-containing lipoproteins.
    Lindén D; Alsterholm M; Wennbo H; Oscarsson J
    J Lipid Res; 2001 Nov; 42(11):1831-40. PubMed ID: 11714852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Very Low Density Lipoprotein Assembly Is Required for cAMP-responsive Element-binding Protein H Processing and Hepatic Apolipoprotein A-IV Expression.
    Cheng D; Xu X; Simon T; Boudyguina E; Deng Z; VerHague M; Lee AH; Shelness GS; Weinberg RB; Parks JS
    J Biol Chem; 2016 Nov; 291(45):23793-23803. PubMed ID: 27655915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complex effects of inhibiting hepatic apolipoprotein B100 synthesis in humans.
    Reyes-Soffer G; Moon B; Hernandez-Ono A; Dionizovik-Dimanovski M; Jimenez J; Obunike J; Thomas T; Ngai C; Fontanez N; Donovan DS; Karmally W; Holleran S; Ramakrishnan R; Mittleman RS; Ginsberg HN
    Sci Transl Med; 2016 Jan; 8(323):323ra12. PubMed ID: 26819195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in fatty acid metabolism in rat hepatocytes in response to dietary n-3 fatty acids are associated with changes in the intracellular metabolism and secretion of apolipoprotein B-48.
    Brown AM; Baker PW; Gibbons GF
    J Lipid Res; 1997 Mar; 38(3):469-81. PubMed ID: 9101428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.